Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Will New COVID-19 Vaccines Affect Risk Stratification?

Listen as expert faculty discuss new COVID-19 vaccines and how they may affect risk stratification of individuals infected with SARS-CoV-2.
Fernando Carnavali, MD
Renslow Sherer, MD
Joseph Torrisi, PharmD, BCIDP
Released: December 27, 2022

Fernando Carnavali, MD; Renslow Sherer, MD; and Joseph Torrisi, PharmD, BCIDP, discuss how new COVID-19 vaccines may affect risk stratification, including:

  • Omicron-specific vaccine
  • Role of vaccination in risk stratification

Information on this Educational Activity

Faculty

Fernando Carnavali, MD

Associate Professor of Medicine
Division Chief
General Internal Medicine
Department of Medicine
Mount Sinai Health System
New York, New York

Fernando Carnavali, MD, has no relevant financial relationships to disclose.
Joseph Torrisi, PharmD, BCIDP

Clinical Pharmacy Specialist, Infectious Diseases
Pharmacy
Grady Health System
Atlanta, Georgia

Joseph Torrisi, PharmD, BCIDP, has no relevant financial relationships to disclose.
Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: unrestricted research grant: Gilead Sciences.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Pfizer, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings